Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析

◆英語タイトル:Suda Pharmaceuticals Ltd (SUD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME19385FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥90,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥135,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria. Suda Pharmaceuticals’ SUD-001 is an oral spray formulation of sumatriptan for the treatment of acute migraine in adults and SUD-003 is an oral spray formulation of sildenafil for the treatment of erectile dysfunction. The company uses OroMist oro-mucosal drug delivery technology to develop pharmaceutical products. It offers its products in forms of tablets and capsules. The company serves pharmacies, hospitals, aged care facilities, mining companies and other healthcare providers. Suda Pharmaceuticals is headquartered in Perth, Western Australia, Australia.

Suda Pharmaceuticals Ltd Key Recent Developments

Jan 25,2021: SUDA Pharmaceuticals :Appendix 4C: second quarter FY 2021 activities report
Dec 16,2020: Laboratorios Ordesa : Feasibility study update
Nov 24,2020: SUDA receives $0.66m R&D tax incentive refund
Oct 26,2020: SUDA Pharmaceuticals : First quarter FY 2021 activities report
Jul 01,2020: SUDA Pharmaceuticals: Joint company secretary and change of registered office

This comprehensive SWOT profile of Suda Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Suda Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Suda Pharmaceuticals Ltd – Key Information
Suda Pharmaceuticals Ltd – Overview
Suda Pharmaceuticals Ltd – Key Employees
Suda Pharmaceuticals Ltd – Key Employee Biographies
Suda Pharmaceuticals Ltd – Key Operational Heads
Suda Pharmaceuticals Ltd – Major Products and Services
Suda Pharmaceuticals Ltd – History
Suda Pharmaceuticals Ltd – Company Statement
Suda Pharmaceuticals Ltd – Locations And Subsidiaries
Suda Pharmaceuticals Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Suda Pharmaceuticals Ltd – Business Description
Suda Pharmaceuticals Ltd – Corporate Strategy
Suda Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Suda Pharmaceuticals Ltd – Strengths
Suda Pharmaceuticals Ltd – Weaknesses
Suda Pharmaceuticals Ltd – Opportunities
Suda Pharmaceuticals Ltd – Threats
Suda Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Suda Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Suda Pharmaceuticals Ltd, Key Information
Suda Pharmaceuticals Ltd, Key Ratios
Suda Pharmaceuticals Ltd, Share Data
Suda Pharmaceuticals Ltd, Major Products and Services
Suda Pharmaceuticals Ltd, History
Suda Pharmaceuticals Ltd, Key Employees
Suda Pharmaceuticals Ltd, Key Employee Biographies
Suda Pharmaceuticals Ltd, Key Operational Heads
Suda Pharmaceuticals Ltd, Other Locations
Suda Pharmaceuticals Ltd, Subsidiaries
Suda Pharmaceuticals Ltd, Key Competitors
Suda Pharmaceuticals Ltd, SWOT Analysis
Suda Pharmaceuticals Ltd, Ratios based on current share price
Suda Pharmaceuticals Ltd, Annual Ratios
Suda Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • MedX Health Corp (MDX):医療機器:M&Aディール及び事業提携情報
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Cosan S.A. Industria e Comercio (CSAN3):企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Xenon Pharmaceuticals Inc (XENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • ProMIS Neurosciences Inc (PMN):製薬・医療:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • Banco do Estado do Rio Grande do Sul SA:企業の戦略・SWOT・財務分析
    Banco do Estado do Rio Grande do Sul SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Estado do Rio Grande do Sul SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Microchip Technology Incorporated:企業のM&A・事業提携・投資動向
    Microchip Technology Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microchip Technology Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Apoteket AB:企業の戦略的SWOT分析
    Apoteket AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Taiwan Semiconductor Manufacturing Company Limited
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • China Aerospace Science and Industry Corp:企業の戦略・SWOT・財務情報
    China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Ubiquiti Networks Inc:企業の戦略・SWOT・財務分析
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Teva Pharmaceutical Industries Limited:企業のM&A・事業提携・投資動向
    Teva Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceutical Industries Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Ceska Sprava Socialniho Zabezpeceni:企業の戦略的SWOT分析
    Ceska Sprava Socialniho Zabezpeceni - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Caris Life Sciences Inc:企業の製品パイプライン分析
    Summary Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a plat …
  • United Biscuits (UK) Limited:企業の戦略・SWOT・財務情報
    United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The Cooper Companies Inc (COO):企業の財務・戦略的SWOT分析
    The Cooper Companies Inc (COO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rengo Co Ltd:企業の戦略・SWOT・財務情報
    Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Marriott International Inc:企業の戦略・SWOT・財務情報
    Marriott International Inc - Strategy, SWOT and Corporate Finance Report Summary Marriott International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆